Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 14 studies | 23% ± 7% | |
oligodendrocyte | 12 studies | 28% ± 11% | |
astrocyte | 10 studies | 34% ± 17% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 11% | |
endothelial cell | 5 studies | 24% ± 7% | |
smooth muscle cell | 5 studies | 23% ± 6% | |
hepatic stellate cell | 3 studies | 25% ± 7% | |
hepatocyte | 3 studies | 42% ± 15% | |
GABAergic neuron | 3 studies | 43% ± 12% | |
glutamatergic neuron | 3 studies | 51% ± 7% | |
pericyte | 3 studies | 25% ± 9% | |
interneuron | 3 studies | 38% ± 16% | |
neuron | 3 studies | 41% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 31% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 304.44 | 459 / 459 | 93% | 11.55 | 1042 / 1118 |
prostate | 99% | 129.68 | 242 / 245 | 94% | 8.72 | 471 / 502 |
lung | 100% | 407.48 | 577 / 578 | 90% | 9.61 | 1045 / 1155 |
liver | 100% | 228.33 | 226 / 226 | 89% | 12.48 | 362 / 406 |
pancreas | 98% | 136.32 | 323 / 328 | 90% | 8.44 | 161 / 178 |
thymus | 100% | 307.52 | 651 / 653 | 88% | 8.79 | 533 / 605 |
kidney | 91% | 112.31 | 81 / 89 | 93% | 15.83 | 837 / 901 |
skin | 100% | 434.00 | 1804 / 1809 | 76% | 13.64 | 359 / 472 |
esophagus | 92% | 171.35 | 1328 / 1445 | 77% | 7.74 | 140 / 183 |
brain | 73% | 86.01 | 1939 / 2642 | 82% | 7.86 | 578 / 705 |
adrenal gland | 99% | 245.86 | 256 / 258 | 55% | 4.15 | 126 / 230 |
uterus | 94% | 133.10 | 160 / 170 | 59% | 5.05 | 272 / 459 |
bladder | 100% | 166.67 | 21 / 21 | 52% | 3.27 | 261 / 504 |
ovary | 97% | 132.91 | 175 / 180 | 53% | 2.51 | 228 / 430 |
stomach | 85% | 84.72 | 304 / 359 | 59% | 4.14 | 170 / 286 |
intestine | 72% | 93.64 | 699 / 966 | 38% | 2.38 | 199 / 527 |
adipose | 100% | 350.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 187.91 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 164.15 | 1236 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 10.55 | 37 / 45 |
heart | 72% | 93.30 | 618 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 3.34 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 28% | 1.05 | 22 / 80 |
peripheral blood | 18% | 187.15 | 164 / 929 | 0% | 0 | 0 / 0 |
muscle | 6% | 4.16 | 48 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0060740 | Biological process | prostate gland epithelium morphogenesis |
GO_0016125 | Biological process | sterol metabolic process |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0035754 | Biological process | B cell chemotaxis |
GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0033783 | Molecular function | 25-hydroxycholesterol 7alpha-hydroxylase activity |
GO_0033782 | Molecular function | 24-hydroxycholesterol 7alpha-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008396 | Molecular function | oxysterol 7-alpha-hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
Gene name | CYP7B1 |
Protein name | CYP7B1 protein Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of endogenous oxysterols and steroid hormones, including neurosteroids . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . Catalyzes the hydroxylation of carbon hydrogen bonds of steroids with a preference for 7-alpha position . Usually metabolizes steroids carrying a hydroxy group at position 3, functioning as a 3-hydroxy steroid 7-alpha hydroxylase . Hydroxylates oxysterols, including 25-hydroxycholesterol and (25R)-cholest-5-ene-3beta,26-diol toward 7-alpha hydroxy derivatives, which may be transported to the liver and converted to bile acids . Via its product 7-alpha,25-dihydroxycholesterol, a ligand for the chemotactic G protein-coupled receptor GPR183/EBI2, regulates B cell migration in germinal centers of lymphoid organs, thus guiding efficient maturation of plasma B cells and overall antigen-specific humoral immune response (By similarity). 7-alpha hydroxylates neurosteroids, including 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone) and pregnenolone, both involved in hippocampus-associated memory and learning . Metabolizes androstanoids toward 6- or 7-alpha hydroxy derivatives . . |
Accessions | Q05C57 O75881 ENST00000310193.4 |